Medicine & TechnologySemaglitude, a medicine used to treat Type 2 diabetes, has now been found to be a game-changing drug for weight loss in patients that struggle with obesity.
In a new study, scientists have presented that adding an investigational cancer drug to an extensively used treatment for diabetes enhances blood sugar control and weight loss in mice.
Lipocalin-2 or LCN2, a type of hormone, could be used as a possible treatment in individuals with obesity whose natural indications for feeling full are no longer working.
For years, researchers have been looking for specific genes associated with obesity. Instead, they found non-coding RNA called microRNA which is linked to metabolic disease and digestion of milk.
Since the pandemic, researchers have reported how people's mental and physical health has declined during the lockdown and home quarantine. The first global survey analyzes these aspects in greater detail, especially for people with obesity.